ST1 Co., Ltd. succeeded in commercializing nanofibers of PCL materials, and is producing nanofiber products for 3D cell culture, which is attracting attention in basic research and new drug development.
By building electrospinning equipment with its own technology, it is possible to produce superior nanofibers with uniform diameters compared to other companies, especially with polymer frame printing technology that serves as a support on the nanofiber surface, it is possible to produce products differentiated from existing nanofibers.
Using this, we have developed Well-INSERT and various disks (PC/PET, nanofibers, collagen membrane, etc.), which are mainly used in cell co-culture experiments.
In addition, we are promoting the expansion of research areas to biomaterials, reconstructive treatment, and various medical devices, and are continuously conducting research to commercialize GBR Membrane, dentine/alveolar bone regeneration, artificial blood vessels, and wound covering products.